Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma

References

• PellegritiG, FrascaF, RegalbutoC, SquatritoS, VigneriR. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212. doi:10.1155/2013/96521223737785
   PubMedGoogle Scholar
• VigneriR, MalandrinoP, VigneriP. The changing epidemiology of thyroid cancer: why is incidence increasing?Curr Opin Oncol. 2015;27(1):1–7. doi:10.1097/CCO.000000000000014825310641
   PubMed Web of Science ®Google Scholar
• CarcangiuML, ZampiG, RosaiJ. Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol. 1984;8(9):655–668. doi:10.1097/00000478-198409000-000056476195
   PubMed Web of Science ®Google Scholar
• DuskovaJ. Known pitfalls of the thyroid neoplasm diagnostics in the view of the new (2004) WHO Classification. Cesk Patol. 2006;42(1):24–28.16506598
   PubMedGoogle Scholar
• KondoT, EzzatS, AsaSL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer. 2006;6(4):292–306. doi:10.1038/nrc183616557281
   PubMed Web of Science ®Google Scholar
• LiVolsiVA, AsaSL. The demise of follicular carcinoma of the thyroid gland. Thyroid. 1994;4(2):233–236. doi:10.1089/thy.1994.4.2337920009
   PubMed Web of Science ®Google Scholar
• MazzaferriEL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol. 1987;14(3):315–332.3306936
   PubMed Web of Science ®Google Scholar
• McCaffreyTV, LiptonRJ. Thyroid carcinoma invading the upper aerodigestive system. Laryngoscope. 1990;100(8):824–830. doi:10.1288/00005537-199008000-000062381258
   PubMed Web of Science ®Google Scholar
• PrasadML, HuangY, PellegataNS, de la ChapelleA, KloosRT. Hashimoto’s thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. Histopathology. 2004;45(1):39–46. doi:10.1111/j.1365-2559.2004.01876.x15228442
   PubMed Web of Science ®Google Scholar
• ZhangX, HongR, ChenW, XuM, WangL. The role of long noncoding RNA in major human disease. Bioorg Chem. 2019;92:103214. doi:10.1016/j.bioorg.2019.10321431499258
   PubMed Web of Science ®Google Scholar
• TanJ, LiuL, ZuoZ, et al. Overexpression of novel long intergenic noncoding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer. Oncol Rep. 2020;44(4):1489–1501.32945494
   PubMed Web of Science ®Google Scholar
• WuL, ShiY, LiuB, ZhaoM. Expression of lncRNA-HOTAIR in the serum of patients with lymph node metastasis of papillary thyroid carcinoma and its impact. Oncol Lett. 2020;20(1):907–913. doi:10.3892/ol.2020.1162032566019
   PubMed Web of Science ®Google Scholar
• XiaF, XiaW, YuX. LncRNA HOTAIR influences the growth, migration, and invasion of papillary thyroid carcinoma via affection on the miR-488-5p/NUP205 axis. Technol Cancer Res Treat. 2020;19:1533033820962125. doi:10.1177/153303382096212533107391
   PubMed Web of Science ®Google Scholar
• JiangY, WangJ, ChenJ, WangJ, XuJ. Construction and analysis of an aberrant lncRNA-miRNA-mRNA network associated with papillary thyroid cancer. Medicine. 2020;99(45):e22705. doi:10.1097/MD.000000000002270533157921
   PubMed Web of Science ®Google Scholar
• Nangia-MakkerP, HoganV, RazA. Galectin-3 and cancer stemness. Glycobiology. 2018;28(4):172–181. doi:10.1093/glycob/cwy00129315388
   PubMed Web of Science ®Google Scholar
• De RoseF, BraeuerM, Braesch-AndersenS, et al. Galectin-3 targeting in thyroid orthotopic tumors opens new ways to characterize thyroid cancer. J Nucl Med. 2019;60(6):770–776. doi:10.2967/jnumed.118.21910530361380
   PubMed Web of Science ®Google Scholar
• IsicT, SavinS, CvejicD, et al. Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors. J Cancer Res Clin Oncol. 2010;136(12):1805–1812. doi:10.1007/s00432-010-0838-320204403
   PubMed Web of Science ®Google Scholar
• MakkiFM, TaylorSM, ShahnavazA, et al. Serum biomarkers of papillary thyroid cancer. J Otolaryngol Head Neck Surg. 2013;42:16. doi:10.1186/1916-0216-42-1623663694
   PubMed Web of Science ®Google Scholar
• ChangL, GuoR, YuanZ, ShiH, ZhangD. LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer. Cell Physiol Biochem. 2018;49(4):1289–1303. doi:10.1159/00049340830205383
   PubMedGoogle Scholar
• XuY, HuJ, ZhangY, et al. LncRNA HOTAIR modulates the expression of OATP1B1 in HepG2 cells by sponging miR-206/miR-613. Xenobiotica. 2020;50(12):1494–1500. doi:10.1080/00498254.2020.177748432486871
   PubMed Web of Science ®Google Scholar
• ZhangJ, LiN, FuJ, ZhouW. Long noncoding RNA HOTAIR promotes medulloblastoma growth, migration and invasion by sponging miR-1/miR-206 and targeting YY1. Biomed Pharmacother. 2020;124:109887. doi:10.1016/j.biopha.2020.10988731986414
   PubMed Web of Science ®Google Scholar
• LiuF, YinR, ChenX, et al. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma. Biomed Pharmacother. 2019;114:108605. doi:10.1016/j.biopha.2019.10860530904818
   PubMed Web of Science ®Google Scholar
• TamS, BoonsripitayanonM, AmitM, et al. Survival in differentiated thyroid cancer: comparing the AJCC cancer staging seventh and eighth editions. Thyroid. 2018;28(10):1301–1310. doi:10.1089/thy.2017.057230141373
   PubMed Web of Science ®Google Scholar
• SchmittgenTD, LivakKJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108. doi:10.1038/nprot.2008.7318546601
   PubMed Web of Science ®Google Scholar
• BergdorfK, FergusonDC, MehradM, ElyK, StrickerT, WeissVL. Papillary thyroid carcinoma behavior: clues in the tumor microenvironment. Endocr Relat Cancer. 2019;26(6):601–614. doi:10.1530/ERC-19-007430965283
   PubMed Web of Science ®Google Scholar
• CanberkS, MontezumaD, InceU, et al. Variants of papillary thyroid carcinoma: an algorithmic cytomorphology-based approach to cytology specimens. Acta Cytol. 2020;64(4):288–298. doi:10.1159/00050357631634886
   PubMed Web of Science ®Google Scholar
• SohSB, AwTC. Laboratory testing in thyroid conditions - pitfalls and clinical utility. Ann Lab Med. 2019;39(1):3–14. doi:10.3343/alm.2019.39.1.330215224
   PubMed Web of Science ®Google Scholar
• HwangS, ShinDY, KimEK, et al. Focal lymphocytic thyroiditis nodules share the features of papillary thyroid cancer on ultrasound. Yonsei Med J. 2015;56(5):1338–1344. doi:10.3349/ymj.2015.56.5.133826256977
   PubMed Web of Science ®Google Scholar
• ZhuH, LvZ, AnC, et al. Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma. Sci Rep. 2016;6:31969. doi:10.1038/srep3196927549736
   PubMed Web of Science ®Google Scholar
• ChenX, JinJ, ZhengL, ShengY, SunJ. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma. J BUON. 2021;26(1):259–265.33721460
   PubMed Web of Science ®Google Scholar
• LiuY, MengH, XuS, QiX. Galectins for diagnosis and prognostic assessment of human diseases: an overview of meta-analyses. Med Sci Monit. 2020;26:e923901. doi:10.12659/MSM.92390132744262
   PubMed Web of Science ®Google Scholar
• ChoH, KimJY, OhYL. Diagnostic value of HBME-1, CK19, Galectin 3, and CD56 in the subtypes of follicular variant of papillary thyroid carcinoma. Pathol Int. 2018;68(11):605–613. doi:10.1111/pin.1272930350394
   PubMed Web of Science ®Google Scholar